Please login to the form below

Not currently logged in
Email:
Password:

transfers of value

This page shows the latest transfers of value news and features for those working in and with pharma, biotech and healthcare.

The future of biotech

The future of biotech

This has not affected technology transfers, an important method of transfering value. ... Italy has introduced innovative schemes to link pricing with value and use of registries.

Latest news

  • Lundbeck challenge to EC pay-for-delay ruling fails Lundbeck challenge to EC pay-for-delay ruling fails

    Court upholds 94m fine for paying off firms to delay launch of Celexa generics. ... value transfers and other inducements," and that the behaviour amounted to a "a buying-off of competition".

  • Counting value under the US Sunshine Act Counting value under the US Sunshine Act

    In February 2013, the Centers for Medicare and Medicaid Services (CMS) published its final rule requiring manufacturers of medicines and medical devices to report payments exceeding $10 or other 'transfers of ... The code requires companies to disclose

  • Pharma paid £38.5m to UK healthcare professionals in 2013 Pharma paid £38.5m to UK healthcare professionals in 2013

    This regulation requires that companies disclose all 'transfers of value' to HCPs for consultancy fees, payment for travel or congress fees etc, as well as a complete ban on all 'gifts'. ... Companies working in the US now also face disclosure of HCP

  • Pharma companies differ on Sunshine Act payment definition Pharma companies differ on Sunshine Act payment definition

    or transfers of value - made to physicians. ... for Shire-sponsored studies was only of benefit for the pharma company and so there was no transfer of value to the physician.

  • EFPIA: Disclose payments or face legislation EFPIA: Disclose payments or face legislation

    EFPIA's code of practice is set to come into force at the beginning of 2014 and includes requirements that companies disclose all 'transfers of value' to HCPs for consultancy fees, ... and healthcare organisations from pharma companies as well as industry

More from news
Approximately 1 fully matching, plus 10 partially matching documents found.

Latest Intelligence

  • Lessons from a squirrel Lessons from a squirrel

    As costs are tightly managed and concerns about transfers of value reporting may result in fewer HCPs travelling to events, how can we be more creative in developing valuable distance-learning ... When a payer does not see the value of a new drug or

  • Counting down to the EFPIA Disclosure Code Counting down to the EFPIA Disclosure Code

    The pan-Europe regulation requires all EFPIA members to reveal any 'transfers of value' made in 2015 by summer next year. ... But this is a massive undertaking, involving an enormous investment of time and resources.

  • 10 ways to meet event disclosure rules 10 ways to meet event disclosure rules

    disclose all transfers of value (TOV) made to HCPs and HCOs in accordance with the 2014 EFPIA Disclosure code. . ... 10 Ways … to meet event disclosure rules focuses on the disclosure of meetings and eventsspend, and Ashfield Meetings &Events

  • The changing regulatory environment The changing regulatory environment

    Key Code updates. EFPIA Code demands that industry declares all transfers of value to healthcare professionals and healthcare organisations. ... EFPIA believes that interactions between the pharmaceutical industry and healthcare professionals have a

More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hamell

Hamell is a full-service agency with a clear focus on delivering evidence-based, sustained behaviour change. So, whether you are looking...

Latest intelligence

NHS regional footprints
What to expect from 2019...
Not another weight-loss ad
Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?...
China’s clinical trial shake-up
As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...

Infographics